Forendo Pharma Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
24
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$955M
Forendo Pharma General Information
Description
Developer of therapeutic drugs designed to assist in the treatment of women's health indications. The company's drugs are competent in tissue-specific hormone mechanisms for the treatment of broader gynecological conditions like endometriotic lesions and polycystic ovarian syndrome, enabling medical professionals to improve the treatment of female urological conditions.
Contact Information
Website
www.forendo.comCorporate Office
- Itäinen Pitkäkatu 4 B
- 20520 Turku
- Finland
Corporate Office
- Itäinen Pitkäkatu 4 B
- 20520 Turku
- Finland
Forendo Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 13-Dec-2021 | $955M | Completed | Clinical Trials - Phase 1 | ||
| 7. Later Stage VC | 03-Dec-2019 | Completed | Clinical Trials - Phase 1 | |||
| 6. Later Stage VC | 17-Jul-2019 | Completed | Clinical Trials - Phase 1 | |||
| 5. Later Stage VC | 05-Sep-2018 | Completed | Clinical Trials - Phase 1 | |||
| 4. Debt - General | 19-Mar-2018 | Completed | Clinical Trials - Phase 1 | |||
| 3. Early Stage VC (Series A) | 23-Oct-2014 | Completed | Startup | |||
| 2. Debt - General | 01-Jan-2014 | $4.59M | Completed | Startup | ||
| 1. Seed Round | 01-Jan-2013 | $4.59M | $4.59M | Completed | Startup |
Forendo Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| B1 shares | ||||||||
| B1 shares | ||||||||
| B1 shares | ||||||||
| Series B | 2,083 | $3340.7 | $3340.7 | 1x | $3340.7 | 13.84% | ||
| Series B | 2,435 | $1587.65 | $1587.65 | 1x | $1587.65 | 13.84% |
Forendo Pharma Comparisons
Industry
Financing
Details
Forendo Pharma Competitors (70)
One of Forendo Pharma’s 70 competitors is NeRRe Therapeutics, a Venture Capital-Backed company based in Stevenage, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NeRRe Therapeutics | Venture Capital-Backed | Stevenage, United Kingdom | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Meditope Biosciences | Formerly VC-backed | Pasadena, CA | ||||
| Sangamo Therapeutics | Formerly VC-backed | Richmond, CA | ||||
| Minerva Neurosciences | Formerly VC-backed | Burlington, MA |
Forendo Pharma Signals
Forendo Pharma Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Finnvera | Lender/Debt Provider | Minority | ||
| Innovestor | Venture Capital | Minority | ||
| KDventures | Venture Capital | Minority | ||
| M Ventures | Corporate Venture Capital | Minority | ||
| Novartis | Corporation | Minority |
Forendo Pharma FAQs
-
When was Forendo Pharma founded?
Forendo Pharma was founded in 2013.
-
Where is Forendo Pharma headquartered?
Forendo Pharma is headquartered in Turku, Finland.
-
What is the size of Forendo Pharma?
Forendo Pharma has 24 total employees.
-
What industry is Forendo Pharma in?
Forendo Pharma’s primary industry is Drug Discovery.
-
Is Forendo Pharma a private or public company?
Forendo Pharma is a Private company.
-
What is the current valuation of Forendo Pharma?
The current valuation of Forendo Pharma is .
-
What is Forendo Pharma’s current revenue?
The current revenue for Forendo Pharma is .
-
How much funding has Forendo Pharma raised over time?
Forendo Pharma has raised $36.7M.
-
Who are Forendo Pharma’s investors?
Finnvera, Innovestor, KDventures, M Ventures, and Novartis are 5 of 9 investors who have invested in Forendo Pharma.
-
Who are Forendo Pharma’s competitors?
NeRRe Therapeutics, Inovio Pharmaceuticals, Meditope Biosciences, Sangamo Therapeutics, and Minerva Neurosciences are some of the 70 competitors of Forendo Pharma.
-
When was Forendo Pharma acquired?
Forendo Pharma was acquired on 13-Dec-2021.
-
Who acquired Forendo Pharma?
Forendo Pharma was acquired by Organon.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process